Risk factors for hospital-acquired antimicrobial-resistant infection caused by Acinetobacter baumannii

scientific article

Risk factors for hospital-acquired antimicrobial-resistant infection caused by Acinetobacter baumannii is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1040366190
P356DOI10.1186/S13756-015-0083-2
P932PMC publication ID4600331
P698PubMed publication ID26457183
P5875ResearchGate publication ID282812347

P50authorElaine LarsonQ95978139
Bevin CohenQ100302797
P2093author name stringJianfang Liu
Darcy Ellis
P2860cites workPrior use of four invasive procedures increases the risk of Acinetobacter baumannii nosocomial bacteremia among patients in intensive care units: a systematic review and meta-analysisQ26997364
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumanniiQ28257612
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007Q28298371
A new method of classifying prognostic comorbidity in longitudinal studies: development and validationQ29547376
Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.Q30580647
Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded databaseQ33364766
Multidrug resistant AcinetobacterQ33711902
Using electronically available inpatient hospital data for researchQ34059172
Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment.Q35005719
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological featuresQ35369996
Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisalQ36150941
The epidemiology and control of Acinetobacter baumannii in health care facilitiesQ36382140
A longitudinal study of Acinetobacter in three Australian hospitals.Q36973909
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment optionsQ37150308
Acinetobacter baumannii: a universal threat to public health?Q37197580
Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalizationQ37302581
Current control and treatment of multidrug-resistant Acinetobacter baumannii infectionsQ37330689
Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health systemQ39922949
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care settingQ43758287
Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequencesQ45048702
Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010.Q47774926
Prevalence and antimicrobial patterns of Acinetobacter baumannii on hands and nares of hospital personnel and patients: the iceberg phenomenon again.Q53947167
Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NYQ80301574
Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomesQ95522530
P921main subjecthospital-acquired infectionQ215509
Acinetobacter baumanniiQ3241189
P304page(s)40
P577publication date2015-10-09
P1433published inAntimicrobial resistance and infection controlQ27724377
P1476titleRisk factors for hospital-acquired antimicrobial-resistant infection caused by Acinetobacter baumannii
P478volume4

Reverse relations

cites work (P2860)
Q60929371A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit
Q33555383Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?
Q57156864The Use of Liquids Ionic Fluids as Pharmaceutically Active Substances Helpful in Combating Nosocomial Infections Induced by New Delhi Strain, and Species
Q55260699Trans-Cinnamaldehyde and Eugenol Increase Acinetobacter baumannii Sensitivity to Beta-Lactam Antibiotics.
Q49321181Unsaturated Fatty Acids Affect Quorum Sensing Communication System and Inhibit Motility and Biofilm Formation of Acinetobacter baumannii

Search more.